A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
Clinical trial NCT02279004 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02279004
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2014-07-03
- Primary completion
- 2026-12-01
- Enrollment
- 840
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.